Department of Health Sciences, Section of Pediatrics, University of Florence, Florence, Italy.
Pediatric Infectious Disease Unit, Anna Meyer Children's University Hospital, Florence, Italy.
Eur J Pediatr. 2022 Dec;181(12):3995-4009. doi: 10.1007/s00431-022-04600-x. Epub 2022 Sep 15.
A systematic literature review was conducted up to 15th February 2022 to summarize long COVID evidence and to assess prevalence and clinical presentation in children and adolescents. Articles reporting long COVID prevalence and symptoms based on original data in the paediatric population were included. Case series quality was assessed through the JBI Critical Appraisal Checklist. For observational studies, adherence to STROBE checklist was evaluated. Twenty-two articles were included: 19 observational studies (12 cohort/7 cross-sectional) and 3 case series. Nine studies provided a control group. We found a high variability in terms of prevalence (1.6-70%). The most frequently reported symptoms were fatigue (2-87%), headache (3.5-80%), arthro-myalgias (5.4-66%), chest tightness or pain (1.4-51%), and dyspnoea (2-57.1%). Five studies reported limitations in daily function due to long COVID. Alterations at brain imaging were described in one study, transient electrocardiographic abnormalities were described in a minority of children, while most authors did not evidence long-term pulmonary sequelae. Older age, female sex, and previous long-term pathological conditions were more frequently associated with persistent symptoms.
Long COVID evidence in children is limited, heterogeneous, and based on low-quality studies. The lockdown consequences are difficult to distinguish from long COVID symptoms. High-quality studies are required: WHO definition of long COVID should be used, controlled clinical studies should be encouraged, and the impact of new variants on long COVID prevalence should be investigated to ensure an objective analysis of long COVID characteristics in children and a proper allocation of healthcare system resources.
• Children rarely develop a severe respiratory disease in the acute phase of COVID-19. • A limited number of patients develop a multisystem inflammatory condition that can lead to multiorgan failure and shock.
• Persistent symptoms after SARS-CoV-2 infection are reported in children and limitations in daily function due to long COVID symptoms affect school attendance. • Functional complaints of post-acute COVID are difficult to be distinguished from those due to social restrictions.
对截至 2022 年 2 月 15 日的文献进行系统性回顾,以总结长新冠在儿童和青少年中的证据,并评估其患病率和临床表现。
纳入报告儿童人群中长新冠患病率和症状的基础上有原始数据的文章。
使用 JBI 批判性评估清单评估病例系列的质量,评估观察性研究时,评估对 STROBE 清单的遵守情况。
共纳入 22 篇文章:19 项观察性研究(12 项队列/7 项横断面研究)和 3 项病例系列研究。9 项研究提供了对照组。我们发现,患病率(1.6%-70%)差异较大。最常报告的症状是疲劳(2%-87%)、头痛(3.5%-80%)、关节痛或肌痛(5.4%-66%)、胸闷或胸痛(1.4%-51%)和呼吸困难(2%-57.1%)。有 5 项研究报告了因长新冠导致的日常功能受限。1 项研究描述了脑部影像学改变,少数儿童出现短暂性心电图异常,而大多数作者没有发现长期肺部后遗症。年龄较大、女性和既往长期疾病状态与持续症状更相关。
儿童长新冠的证据有限、异质性大,且基于低质量研究。锁定后果难以与长新冠症状区分。需要开展高质量研究:应使用世卫组织长新冠定义,鼓励开展对照临床研究,并研究新变异对长新冠患病率的影响,以确保对儿童长新冠特征进行客观分析,并合理分配医疗系统资源。
儿童在 COVID-19 急性期中很少发生严重呼吸道疾病。少数患者会发生多系统炎症,可导致多器官衰竭和休克。
SARS-CoV-2 感染后持续存在的症状在儿童中被报告,长新冠引起的日常功能受限会影响上学出勤率。急性新冠后的功能抱怨很难与因社会限制引起的抱怨区分开来。